Show simple item record

dc.contributor.advisorFranzblau, Carlen_US
dc.contributor.advisorHickey, Patricken_US
dc.contributor.authorLukish, Johnen_US
dc.date.accessioned2019-12-05T19:43:32Z
dc.date.available2019-12-05T19:43:32Z
dc.date.issued2019
dc.identifier.urihttps://hdl.handle.net/2144/38678
dc.description.abstractThere is clear evidence that obesity and asthma are among today’s most prevalent, threatening, and burdensome childhood afflictions. Research strongly suggests that these two disorders, when occurring concurrently, are in fact, a distinct disease state. There exists two prominent asthma phenotypes, both of which are related in different degrees with obesity. These are early-onset, atopic and late-onset, non-atopic obesity-related asthma. The linkage between obesity and asthma is complex as both disorders cause a variety of metabolic and immunological changes that can affect different, yet interconnecting compartments and functions of the body. The main objective of this review is to summarize the principal findings that pathologically link obesity and asthma and the pharmacologic and non-pharmacologic therapies that are currently in use to combat this disorder.en_US
dc.language.isoen_US
dc.subjectPhysiologyen_US
dc.titleThe pathology and treatment of pediatric obesity-related asthmaen_US
dc.typeThesis/Dissertationen_US
dc.date.updated2019-10-10T01:03:30Z
etd.degree.nameMaster of Scienceen_US
etd.degree.levelmastersen_US
etd.degree.disciplineMedical Sciencesen_US
etd.degree.grantorBoston Universityen_US


This item appears in the following Collection(s)

Show simple item record